Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Omnicell Inc

OC9
Current price
40.2 EUR +1.79 EUR (+4.69%)
Last closed 43.16 USD
ISIN US68213N1090
Sector Healthcare
Industry Health Information Services
Exchange Stuttgart Exchange
Capitalization 1 985 092 352 USD
Yield for 12 month -16.68 %
1Y
3Y
5Y
10Y
15Y
OC9
21.11.2021 - 28.11.2021

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas. Address: 4220 North Freeway, Fort Worth, TX, United States, 76137

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

44.5 USD

P/E ratio

Dividend Yield

Current Year

+1 147 112 000 USD

Last Year

+1 295 947 000 USD

Current Quarter

+276 788 000 USD

Last Quarter

+246 151 000 USD

Current Year

+496 840 000 USD

Last Year

+588 987 000 USD

Current Quarter

+114 351 000 USD

Last Quarter

+95 319 000 USD

Key Figures OC9

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 22 729 000 USD
Operating Margin TTM 1.17 %
PE Ratio
Return On Assets TTM -0.99 %
PEG Ratio 2.28
Return On Equity TTM -1.75 %
Wall Street Target Price 44.5 USD
Revenue TTM 1 080 449 024 USD
Book Value 26.15 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -7.4 %
Dividend Yield
Gross Profit TTM 596 705 000 USD
Earnings per share -0.45 USD
Diluted Eps TTM -0.45 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 4.6 %
Profit Margin -1.92 %

Dividend Analytics OC9

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OC9

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation OC9

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 29.4985
Enterprise Value Revenue 1.8799
Price Sales TTM 1.8373
Enterprise Value EBITDA 36.9348
Price Book MRQ 1.6504

Financials OC9

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OC9

For 52 weeks

25.12 USD 56.05 USD
50 Day MA 37.06 USD
Shares Short Prior Month 1 983 615
200 Day MA 32.23 USD
Short Ratio 3.79
Shares Short 2 255 435
Short Percent 7.09 %